2026年10月20日 8:50 ET 发布 · 更新于 24 天前 · 2 个来源
Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis
CNBC Markets
·
原始报道
Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.
原文